CTLA4 and neoplasm: The tumor cells use mechanisms such as the up-regulation of immune checkpoint signaling programmed death-ligand 1 (PD-L1), downregulation of cytotoxic T-lymphocyte-associated protein 4 (CTLA4), and the recruitment of MDSCs, to evade the immune system [43–45].